gmpnews-1-2017-annonceRussian Magazine for the Leaders of Pharmaceutical Industry
Subscribe for free!
(In Russian)

TOP News

Vialek Book Banner

Bayer got FDA approval for liver cancer drug

Bayer announced that the U.S. Food and Drug Administration (FDA) approved Stivarga® (regorafenib) tablets for the second-line treatment of patients with hepatocellular carcinoma (HCC) who have been pr...

HIV market will increase to $22.5 billion by 2025

hiv drugs
The human immunodeficiency virus (HIV) market across the nine major countries of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, and China, is set to grow from $16.3 billion in 2015 to $...

Eurasian Intergovernmental Council will set exclusions for “parallel” imports

At its meeting, the Board of the Eurasian Economic Commission (EEC) approved the draft Protocol on Amendments to the Treaty on the Eurasian Economic Union of May 29, 2014. The document grants the E...

Trials conducted by ChemRar confirm the safety of a new anti-flu medicine

ChemRar Group announced successful completion of clinical trials to assess safety and tolerability of AV5080, a fundamentally new oral drug candidate formulation with a broad spectrum of anti-flu acti...

NANOLEK will supply Tepadina to the Russian market

NANOLEK announced its cooperation with RIMZER Pharma GmbH (Germany), which will open the door to NANOLEK to distribute Tepadina® (LP-001134 Adienne S.r.l.; INN: thiotepa) in Russia. Thiotepa is used a...

Merck sold its biosimilars business to Fresenius

Merck has divested its biosimilars business to German company Fresenius in a deal potentially worth 670 million euros. The move is aligned with a strategy of focusing on innovative medicines while ena...

New product of R-Pharm will reduce the cost of HCV treatment

On April 25, Vladimir Putin met the representatives of businesses in the Yaroslavl region. The event was attended by Vasily Ignatiev, the CEO of R-Pharm Group. The CEO of R-Pharm mentioned the suppor...

Subscribe to GMP news Newsletter!

Pharmcontract Banner


National producers entered the market with nearly a dozen of biosimilars

Denis Manturov
Denis Manturov told the correspondent of "Expert" magazine how the Ministry for Industry & Trade continues to work towards technical upgrading of the Russian industry, about current progress in th...

The long and expensive process to enter the international market

Nikolai Yemelianov - Niarmedic Plus
What is the difference between the native antiviral drugs and imported ones and what is necessary for their entry into foreign markets, described the head of the Department of medical research and inf...

Modern Russian enterprises are not inferior in terms of quality to the foreign facilities

The 19th International Exhibition of equipment, raw materials and technologies for pharmaceutical production – Pharmtech & Ingredients 2016 – was held on November 22-25, 2016.   On the first da...

Subscribe to GMP news Newsletter!